225 related articles for article (PubMed ID: 21255435)
41. Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.
Li Y; Nie Y; Tu S; Wang H; Zhou Y; Du Y; Cao J; Ye M
Oncol Rep; 2016 Oct; 36(4):2108-16. PubMed ID: 27498672
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression.
Carden T; Singh B; Mooga V; Bajpai P; Singh KK
J Biol Chem; 2017 Dec; 292(50):20694-20706. PubMed ID: 29066618
[TBL] [Abstract][Full Text] [Related]
43. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
44. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
45. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells.
de Souza Rocha Simonini P; Breiling A; Gupta N; Malekpour M; Youns M; Omranipour R; Malekpour F; Volinia S; Croce CM; Najmabadi H; Diederichs S; Sahin O; Mayer D; Lyko F; Hoheisel JD; Riazalhosseini Y
Cancer Res; 2010 Nov; 70(22):9175-84. PubMed ID: 20978187
[TBL] [Abstract][Full Text] [Related]
46. Epigenetically regulated microRNAs in Alzheimer's disease.
Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
[TBL] [Abstract][Full Text] [Related]
47. Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma.
Goeppert B; Ernst C; Baer C; Roessler S; Renner M; Mehrabi A; Hafezi M; Pathil A; Warth A; Stenzinger A; Weichert W; Bähr M; Will R; Schirmacher P; Plass C; Weichenhan D
Epigenetics; 2016 Nov; 11(11):780-790. PubMed ID: 27593557
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
49. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment.
Costa FF; Seftor EA; Bischof JM; Kirschmann DA; Strizzi L; Arndt K; Bonaldo Mde F; Soares MB; Hendrix MJ
Epigenomics; 2009 Dec; 1(2):387-98. PubMed ID: 20495621
[TBL] [Abstract][Full Text] [Related]
50. Crosstalk between miRNAs and DNA Methylation in Cancer.
Saviana M; Le P; Micalo L; Del Valle-Morales D; Romano G; Acunzo M; Li H; Nana-Sinkam P
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239435
[TBL] [Abstract][Full Text] [Related]
51. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
[TBL] [Abstract][Full Text] [Related]
52. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
53. Genetic and epigenetic factors in regulation of microRNA in colorectal cancers.
Vinci S; Gelmini S; Mancini I; Malentacchi F; Pazzagli M; Beltrami C; Pinzani P; Orlando C
Methods; 2013 Jan; 59(1):138-46. PubMed ID: 22989523
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
[TBL] [Abstract][Full Text] [Related]
55. Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.
Dayakar A; Shanmukha KD; Kalangi SK
Mol Biol Rep; 2022 Jul; 49(7):6827-6846. PubMed ID: 35031927
[TBL] [Abstract][Full Text] [Related]
56. miRNAs and cancer: an epigenetics view.
Malumbres M
Mol Aspects Med; 2013; 34(4):863-74. PubMed ID: 22771542
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA epigenetic signatures in human disease.
Piletič K; Kunej T
Arch Toxicol; 2016 Oct; 90(10):2405-19. PubMed ID: 27557899
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation.
Parodi F; Carosio R; Ragusa M; Di Pietro C; Maugeri M; Barbagallo D; Sallustio F; Allemanni G; Pistillo MP; Casciano I; Forlani A; Schena FP; Purrello M; Romani M; Banelli B
Biochim Biophys Acta; 2016 Dec; 1859(12):1502-1514. PubMed ID: 27751904
[TBL] [Abstract][Full Text] [Related]
60. miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.
Rauhala HE; Jalava SE; Isotalo J; Bracken H; Lehmusvaara S; Tammela TL; Oja H; Visakorpi T
Int J Cancer; 2010 Sep; 127(6):1363-72. PubMed ID: 20073067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
